Meta-analysis of 5 studies (1,593,554 patients): semaglutide use was associated with higher risk of NAION vs non-GLP-1RA use (RR 2.52, 95% CrI 1.56-4.72), particularly in diabetes (RR 2.41); certainty of evidence was low to moderate.
Meta-analysisn = 1,593,554
Dhivagaran et al. Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy: Systematic Review and Meta-Analysis